Perella Weinberg Partners Advises Rapid Micro Biosystems on Acquisition by Merck KGaA
Perella Weinberg Partners is serving as the financial advisor to Rapid Micro Biosystems in its definitive agreement to be acquired by Merck KGaA for $0.75 per share.